The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis (Q59689568)

From Wikidata
Jump to navigation Jump to search
scholarly article by G A Ellard et al published June 1986 in The American Review of Respiratory Disease
edit
Language Label Description Also known as
English
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis
scholarly article by G A Ellard et al published June 1986 in The American Review of Respiratory Disease

    Statements

    The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis (English)
    0 references
    G A Ellard
    0 references
    D R Ellard
    0 references
    B W Allen
    0 references
    D J Girling
    0 references
    A J Nunn
    0 references
    S K Teo
    0 references
    T H Tan
    0 references
    H K Ng
    0 references
    S L Chan
    0 references
    June 1986
    0 references
    133
    0 references
    6
    0 references
    1076-80
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit